Investigational drug · Phase 2
EXE-346
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Ileal Pouch.
Phase 2Last checked: Nov 19, 2026Latest source record: May 28, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "EXE-346"
First trial start
2023
Nov 6, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "EXE-346", any sponsor or status.
Conditions studied
As listed on its trial records.
- Ileal Pouch
Largest trials
Live from ClinicalTrials.gov: studies naming "EXE-346" as an intervention, largest first.
University of California, San FranciscoAcademic, hospital or other
NCT06949800 · 90 participants (planned) · Start Sep 4, 2026 · Primary completion Oct 31, 2027
Drug: EXE-346 Probiotic; Placebo · For: HSIL, High Grade Squamous Intraepithelial Lesion; HPV-Related Squamous Cell Carcinoma; Anal HSIL
Sites: San Francisco, California; San Juan, Puerto Rico
Exegi Pharma, LLCIndustry
NCT05938465 · 50 participants (planned) · Start Nov 6, 2023 · Primary completion May 31, 2027
Drug: EXE-346 · For: Ileal Pouch
Sites: Los Angeles, California; Jacksonville, Florida; Grand Rapids, Michigan · 8 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.